SUS Surgical Science Sweden AB (publ)
Surgical Science Sweden AB (publ) develops and markets virtual reality simulators and customized training solutions for evidence-based medical training in Europe, North and South America, Asia, and internationally. The company offers Angio Mentor simulator for endovascular training; BRONCH Express, a portable version of BRONCH mentor simulator; ARTHRO Mentor for arthroscopic surgery skills acquisition; BRONCH Mentor, a simulator for optimizing bronchoscopy training; GI Mentor, a simulator for GI Endoscopy; HYST Mentor for True-To-Life diagnostic and therapeutic hysteroscopy training; URO Mentor, a virtual reality simulator for endourology training; EndoSim, a realistic scope simulator; FlexVR, a flexible and portable training platform which is designed to teach basic and advanced skills for robotic surgery; and LAP Mentor provides a wide array of laparoscopic training cases. It also provides LapSim training system comprising LapSim Haptic simulator that provides laparoscopic training; LapSim essence, a portable and ready-to-use VR simulator; and LapSim 360, which provides a high-immersion virtual reality training experience; MentorLearn, an end-to-end educational platform that makes simulation course management; and LapSim ST, a training system that prepares students for the operating room. In addition, the company offers PELVIC Mentor simulator provides anatomy and pelvic exam training; Perc Mentor suite for image-guided interventions; RobotiX Mentor for practice the motor and cognitive skills for surgeons; Simball Box, which combines with digitally collected metrics into a training tool; Spine Mentor, a training simulator for minimal invasive spine surgery; TEE Express, designed to teach Trans-Esophageal Echocardiography procedure using a TEE probe; TraumaVR, an ultimate mix of manikin and VR simulation; and Ultrasound Mentor for ultrasound training with multiple medical specialties. Surgical Science AB was founded in 1997 and is based in Gothenburg, Sweden.…
Industry Peers
Health Information ServicesKey Statistics
About Surgical Science Sweden (STO: SUS)
›
Surgical Science Sweden (STO: SUS) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Health Information Services industry, part of the Healthcare sector, and reports about 313 employees.
The shares were at 59.65 SEK on 19 November 2026, down 28.1% over 52 weeks. Its 52-week range is 23.70 SEK to 85.00 SEK: the price is 29.8% below the high and 151.7% above the low.
At a market capitalisation of 3.04B SEK, it trades at 28.5 times trailing earnings and 12.2 times forward earnings. The median trailing P/E of its 14 largest Health Information Services peers is 42.1, a discount of 32% for SUS.
Surgical Science Sweden reports return on equity of 1.6%, an operating margin of 13.1% and revenue down 1.3% year over year.
It holds more cash than debt, a net cash position of 672.06M SEK. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 72.20 SEK is 21.0% above the current price. The next earnings report is expected on 23 February 2027.